Wednesday 24th February 2021 |
Text too small? |
The Group is on target to achieve global case sales for the full year of 3,391,000, up 3% on last year. Based on prevailing exchange rates, the Group forecasts a 2021 Operating Profit result of $67 million, up on last year’s performance by 10%.
A record Operating NPAT of $43.1 million was generated compared to $34.4 million for the same period the previous year. Operating EBIT of $64.5 million is $11.0 million higher than for the same period the previous year.
Delegat achieved Operating Revenue of $172.8 million on global case sales of 1,862,000 in the six month period. Revenue is up $16.1 million on the same period last year due to a 7% increase in global case sales and the favourable impact of market and product mix.
Operating Gross Profit is up 10% on the same period last year. This is due to the increased case sales and favourable impact of market and product mix, which have offset an unfavourable impact of foreign exchange rate changes. Operating expenses (before NZ IFRS adjustments) at $26.3 million are $2.8 million lower compared to the same period in the previous year. This is primarily due to the impact of COVID-19 restrictions in the current year, whereby travel, entertainment and other operating expenses have been restricted in most markets.
Please see the links below for details:
DGL - Interim Results Powerpoint presentation to 31 Dec 2020
DGL - Interim Results to 31 Dec 2020
No comments yet
FPH launches F&P Nova™ Nasal mask in NZ and AU
Fonterra announces changes to management team
March 12th Morning Report
WHS FY25 Interim Results teleconference details
VGL - Odeon Cinemas Group signs for Vista Cloud
DGL - T&G appoints new Director
TEM - Transaction in Own Shares
Fonterra lifts FY25 earnings guidance
Fonterra releases divestment roadshow presentation
March 10th Morning Report